Faculty
Karel Allegaert, Belgium
NICU Leuven, Leuven
Prof dr Karel Allegaert, MD, PhD
Research fields:
Perinatal pharmacology
Pediatric pain
Clinical pharmacology (newborn, infant)
Current positions:
Consultant, NICU Leuven, Belgium
Professor, KU Leuven, Belgium
Council member ESPR, ESDPP
Scientific output:
About 240 PubMed citations and 12 chapters of textbooks, mainly related to perinatal pharmacology, pediatric pain and topics on clinical neonatology.
Aayed Alqahtani, Saudi Arabia
King Saud University, Riyadh
Prof., Aayed Alqahtani, MD, FRCSC, FACS He received his medical education with honors from King Saud University, Riyadh. He did his post graduate training in McGill University, obtained his fellowship (FRCSC) in general surgery from the Royal College of Physician & Surgeon of Canada and the American Board of General Surgery (FACS) with specialized training in minimally invasive surgery at McGill University Canada and Denver, USA.He is currently a Professor and a Consultant of MIS and Obesity Surgery at King Saud University. He is the Director of King Saud’s University’s Obesity Chair and one of the prominent bariatric surgeons worldwide.
He has published many articles, chapters and books. He has been the guest speakers in more than 100 international events and over 200 peer-reviewed presentations at national and inter-national meetings. He is faculty of many national and international training courses and workshop in MIS, Robotic and Obesity. He is very active in numerous national and international societies, and he is a reviewer and sits on the editorial board of many respected medical journals.
Johannes van den Anker, USA/Switzerland
George Washington University
Prof. Johannes van den Anker received his MD and PhD from the Erasmus University in Rotterdam, the Netherlands. Since 2002 he has been the Vice Chair of Pediatrics for Experimental Therapeutics and the Evan and Jones Chair in Pediatric Clinical Pharmacology at Children’s National Medical Center in Washington, and Professor of Pediatrics, Integrative Systems Biology, Pharmacology & Physiology at George Washington University School of Medicine and Health Sciences. His expertise is in developmental, neonatal and paediatric pharmacology.
He has major awards from the National Institute of Health (NIH) and leads one of only four NICHD-funded Research Centers Specialized in Pediatric Developmental Pharmacology. He has published over 300 peer reviewed papers and is member of the Editorial Board of several clinical pharmacology journals.
In 2014 he was appointed as Eckenstein-Geigy Professor of Paediatric Pharmacology at the University of Basel in Switzerland.
He is currently member of the Committee on Drugs of the American Academy of Pediatrics, President-elect of the American College of Clinical Pharmacology, and President-elect of the European Society for Developmental, Perinatal and Paediatric Pharmacology.
Jordi Anton, Spain
University of Barcelona
Prof. Jordi Anton, MD, Phd
Abridged Curriculum Vitae
Full Name: Jordi Antón
Date of Birth: 3rd august 1968
Nationality: Spanish
Academic Title: Pediatrician, MD, PhD
Present Position (including name and address of the institution):
Senior Attendant. Pediatric Rheumatology Unit. Pediatrics Department.
Hospital Sant Joan de Deu
University of Barcelona.
Paaseig Sant Joan de Deu, 2. 08950 Esplugues (Barcelona)
Starting Date in this Position: September 2003
Relevant Professional Qualifications (Post Graduate Training):
Qualification Dates
Pediatrics 1994-1997
Pediatric rheumatology 1999-2000
Associate professor. University of Barcelona 2005-
Relevant Experience / Positions (Responsibility/Years):
Experience Dates
Pediatrics Departament. Hospital of Sabadell. Corporaciò Parc Taulí 1998-2003
President. Spanish Pediatric Rheumatology Society (SERPE) 2011-
Other relevant information (e.g. Publications, participation in International Conferences/Clinical Trials):
Dates
1: Minoia F, Davì S, Horne A, Demirkaya E, Bovis F, Li C, Lehmberg K, Weitzman S, Insalaco A, Wouters C, Shenoi S, Espada G, Ozen S, Anton J, Khubchandani R, Russo R, Pal P, Kasapcopur O, Miettunen P, Maritsi D, Merino R, Shakoory B, Alessio M, Chasnyk V, Sanner H, Gao Y, Huasong Z, Kitoh T, Avcin T, Fischbach M, Frosch M, Grom A, Huber A, Jelusic M, Sawhney S, Uziel Y, Ruperto N, Martini A, Cron RQ, Ravelli A; on behalf of the Pediatric Rheumatology International Trials Organization; the Childhood Arthritis & Rheumatology Research Alliance; the Pediatric Rheumatology Collaborative Study Group, and the Histiocyte Society. Clinical features, treatment and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis A multinational, multicenter study of 362 patients. Arthritis Rheumatol. 2014 Jul 30. doi: 10.1002/art.38802.
[Epub ahead of print]
2: Giménez-Roca C, Iglesias E, Torrente-Segarra V, Bou R, Sánchez-Manubens J, Calzada-Hernández J, Hernández S, Ricart S, Antón J. Efficacy and safety of TNF-alpha antagonists in children with juvenile idiopathic arthritis who started treatment under 4 years of age. Rheumatol Int. 2014 Aug 3. [Epub ahead of print]
3: Baroja-Mazo A, Martín-Sánchez F, Gomez AI, Martínez CM, Amores-Iniesta J, Compan V, Barberà-Cremades M, Yagüe J, Ruiz-Ortiz E, Antón J, Buján S, Couillin I, Brough D, Arostegui JI, Pelegrín P. The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response. Nat Immunol. 2014 Aug;15(8):738-48.
4: Bou R, Iglesias E, Antón J. Treatment of uveitis associated with juvenile
idiopathic arthritis. Curr Rheumatol Rep. 2014 Aug;16(8):437.
5: Hofer M, Pillet P, Cochard MM, Berg S, Krol P, Kone-Paut I, Rigante D, Hentgen V, Anton J, Brik R, Neven B, Touitou I, Kaiser D, Duquesne A, Wouters C, Gattorno M. International periodic fever, aphthous stomatitis, pharyngitis, cervical adenitis syndrome cohort: description of distinct phenotypes in 301 patients. Rheumatology (Oxford). 2014 Jun;53(6):1125-9.
6: García-De-Vicuña C, Díaz-Llopis M, Salom D, Bou R, Díaz-Cascajosa J,
Cordero-Coma M, Ortega G, Ortego-Centeno N, Suarez-De-Figueroa M, Cruz-Martínez J, Fonollosa A, Blanco R, García-Aparicio ÁM, Benítez-Del-Castillo JM, Antón J. Usefulness of adalimumab in the treatment of refractory uveitis associated with juvenile idiopathic arthritis. Mediators Inflamm. 2013;2013:560632.
7: Sánchez-Manubens J, Bou R, Anton J. Diagnosis and classification of Kawasaki disease. J Autoimmun. 2014 Feb-Mar;48-49:113-7.
8. Nakagawa K, Gonzalez-Roca E, Souto A, Kawai T, Umebayashi H, Campistol JM, Cañellas J, Takei S, Kobayashi N, Callejas-Rubio JL, Ortego-Centeno N, Ruiz-Ortiz E, Rius F, Anton J, Iglesias E, Jimenez-Treviño S, Vargas C, Fernandez-Martin J, Calvo I, Hernández-Rodríguez J, Mendez M, Dordal MT, Basagaña M, Bujan S, Yashiro M, Kubota T, Koike R, Akuta N, Shimoyama K, Iwata N, Saito MK, Ohara O, Kambe N, Yasumi T, Izawa K, Kawai T, Heike T, Yagüe J, Nishikomori R, Aróstegui JI. Somatic NLRP3 mosaicism in Muckle-Wells syndrome. A genetic mechanism shared by
different phenotypes of cryopyrin-associated periodic syndromes. Ann Rheum Dis. 2013 Dec 10. [Epub ahead of print]
9. Iglesias E, Torrente-Segarra V, Bou R, Ricart S, González MI, Sánchez J,
Calzada J, Antón J. Non-systemic juvenile idiopathic arthritis outcome after
reaching clinical remission with anti-TNF-α therapy: a clinical practice
observational study of patients who discontinued treatment. Rheumatol Int. 2013 Oct 26. [Epub ahead of print]
10: Pelegrín L, Casaroli-Marano R, Antón J, Carmen García de Vicuña M, Molina-Prat N, Ignacio Aróstegui J, Yagüe J, Ríos J, Adán A. Predictive Value of Selected Biomarkers, Polymorphisms, and Clinical Features for Oligoarticular Juvenile Idiopathic Arthritis-associated Uveitis. Ocul Immunol Inflamm. 2013 Oct 16. [Epub ahead of print].
11: Burns JC, Herzog L, Fabri O, Tremoulet AH, Rodó X, Uehara R, Burgner D, Bainto E, Pierce D, Tyree M, Cayan D; Kawasaki Disease Global Climate Consortium. Seasonality of Kawasaki disease: a global perspective. PLoS One. 2013 Sep 18;8(9):e74529.
12: Lachmann HJ, Papa R, Gerhold K, Obici L, Touitou I, Cantarini L, Frenkel J, Anton J, Kone-Paut I, Cattalini M, Bader-Meunier B, Insalaco A, Hentgen V, Merino R, Modesto C, Toplak N, Berendes R, Ozen S, Cimaz R, Jansson A, Brogan PA, Hawkins PN, Ruperto N, Martini A, Woo P, Gattorno M; for the Paediatric Rheumatology International Trials Organisation (PRINTO), the EUROTRAPS and the Eurofever Project. The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever/EUROTRAPS international registry. Ann Rheum Dis. 2013 Aug 21. [Epub ahead of print]
13: Bishop N, Adami S, Ahmed SF, Antón J, Arundel P, Burren CP, Devogelaer JP, Hangartner T, Hosszú E, Lane JM, Lorenc R, Mäkitie O, Munns CF, Paredes A, Pavlov H, Plotkin H, Raggio CL, Reyes ML, Schoenau E, Semler O, Sillence DO, Steiner RD. Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trial. Lancet. 2013 Oct 26;382(9902):1424-32
14: Iglesias E, Jou C, Bou R, Antón J. [Importance of muscle biopsy in the
diagnosis of juvenile dermatomyositis]. An Pediatr (Barc). 2014 Feb;80(2):e25-6.
15: Sarrión P, Sangorrin A, Urreizti R, Delgado A, Artuch R, Martorell L,
Armstrong J, Anton J, Torner F, Vilaseca MA, Nevado J, Lapunzina P, Asteggiano CG, Balcells S, Grinberg D. Mutations in the EXT1 and EXT2 genes in Spanish patients with multiple osteochondromas. Sci Rep. 2013;3:1346.
16: Kimura Y, Weiss JE, Haroldson KL, Lee T, Punaro M, Oliveira S, Rabinovich E, Riebschleger M, Antón J, Blier PR, Gerloni V, Hazen MM, Kessler E, Onel K, Passo MH, Rennebohm RM, Wallace CA, Woo P, Wulffraat N; Childhood Arthritis Rheumatology Research Alliance Carra Net Investigators. Pulmonary hypertension and other potentially fatal pulmonary complications in systemic juvenile idiopathic arthritis. Arthritis Care Res (Hoboken). 2013 May;65(5):745-52.
17: Dolezalova P, Price-Kuehne FE, Özen S, Benseler SM, Cabral DA, Anton J, Brunner J, Cimaz R, O’Neil KM, Wallace CA, Wilkinson N, Eleftheriou D, Demirkaya E, Böhm M, Krol P, Luqmani RA, Brogan PA. Disease activity assessment in childhood vasculitis: development and preliminary validation of the Paediatric Vasculitis Activity Score (PVAS). Ann Rheum Dis. 2013 Oct;72(10):1628-33.
18: Ter Haar N, Lachmann H, Özen S, Woo P, Uziel Y, Modesto C, Koné-Paut I, Cantarini L, Insalaco A, Neven B, Hofer M, Rigante D, Al-Mayouf S, Touitou I, Gallizzi R, Papadopoulou-Alataki E, Martino S, Kuemmerle-Deschner J, Obici L, Iagaru N, Simon A, Nielsen S, Martini A, Ruperto N, Gattorno M, Frenkel J; Paediatric Rheumatology International Trials Organisation (PRINTO) and the Eurofever/Eurotraps Projects. Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review. Ann Rheum Dis. 2013 May;72(5):678-85.
19: Gerss J, Roth J, Holzinger D, Ruperto N, Wittkowski H, Frosch M, Wulffraat N, Wedderburn L, Stanevicha V, Mihaylova D, Harjacek M, Len C, Toppino C, Masi M, Minden K, Saurenmann T, Uziel Y, Vesely R, Apaz MT, Kuester RM, Elorduy MJ, Burgos-Vargas R, Ioseliani M, Magni-Manzoni S, Unsal E, Anton J, Balogh Z, Hagelberg S, Mazur-Zielinska H, Tauber T, Martini A, Foell D; Paediatric Rheumatology International Trials Organization (PRINTO). Phagocyte-specific S100 proteins and high-sensitivity C reactive protein as biomarkers for a risk-adapted treatment to maintain remission in juvenile idiopathic arthritis: a comparative study. Ann Rheum Dis. 2012 Dec; 71(12): 1991-7..
20: Heiligenhaus A, Foeldvari I, Edelsten C, Smith JR, Saurenmann RK, Bodaghi B, de Boer J, Graham E, Anton J, Kotaniemi K, Mackensen F, Minden K, Nielsen S, Rabinovich EC, Ramanan AV, Strand V; Multinational Interdisciplinary Working Group for Uveitis in Childhood. Proposed outcome measures for prospective clinical trials in juvenile idiopathic arthritis-associated uveitis: a consensus effort from the multinational interdisciplinary working group for uveitis in childhood. Arthritis Care Res (Hoboken). 2012 Sep;64(9):1365-72.
21: Márquez Balbás G, González-Enseñat MA, Vicente A, Creus-Vila L, Antón J, Umbert-Millet P. Incontinentia pigmenti and bipolar aphthosis: an unusual
combination. ISRN Dermatol. 2011;2011:814186.
22: Antón J. [Autoinflammatory syndromes]. Med Clin (Barc). 2011 Jan;136 Suppl 1:3-9.
23: Koné-Paut I, Darce-Bello M, Shahram F, Gattorno M, Cimaz R, Ozen S, Cantarini L, Tugal-Tutktun I, Assaad-Khalil S, Hofer M, Kuemmerle-Deschner J, Benamour S, Al Mayouf S, Pajot C, Anton J, Faye A, Bono W, Nielsen S, Letierce A, Tran TA; PED-BD International Expert Committee. Registries in rheumatological and musculoskeletal conditions. Paediatric Behçet’s disease: an international cohort study of 110 patients. One-year follow-up data. Rheumatology (Oxford). 2011 Jan;50(1):184-8.
24: Modesto C, Antón J, Rodriguez B, Bou R, Arnal C, Ros J, Tena X, Rodrigo C, Rotés I, Hermosilla E, Barceló P. Incidence and prevalence of juvenile idiopathic arthritis in Catalonia (Spain). Scand J Rheumatol. 2010 Nov;39(6):472-9.
25: Ruperto N, Ozen S, Pistorio A, Dolezalova P, Brogan P, Cabral DA, Cuttica R, Khubchandani R, Lovell DJ, O’Neil KM, Quartier P, Ravelli A, Iusan SM, Filocamo G, Magalhães CS, Unsal E, Oliveira S, Bracaglia C, Bagga A, Stanevicha V, Manzoni SM, Pratsidou P, Lepore L, Espada G, Kone-Paut I, Zulian F, Barone P, Bircan Z, Maldonado Mdel R, Russo R, Vilca I, Tullus K, Cimaz R, Horneff G, Anton J, Garay S, Nielsen S, Barbano G, Martini A; Paediatric Rheumatology International Trials Organisation (PRINTO). EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura,
childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part I: Overall methodology and clinical characterisation. Ann Rheum Dis. 2010 May;69(5):790-7.
26: Moorthy LN, Peterson MG, Baratelli M, Hassett AL, Lehman TJ; International SMILEY Collaborative Group. Preliminary cross-cultural adaptation of a new pediatric health-related quality of life scale in children with systemic lupus erythematosus: an international effort. Lupus. 2010 Jan;19(1):83-8.
27: Serrano M, Ormazábal A, Antón J, Aróstegui JI, García-Cazorla A.
Cerebrospinal fluid neopterin and cryopyrin-associated periodic syndrome. Pediatr Neurol. 2009 Dec;41(6):448-50.
28: Marín-Valencia I, Antón J, Ros J, Cols M. Severe generalized oedema with
haemodynamic instability in a previously healthy patient (Case Presentation).
Acta Paediatr. 2009 Mar;98(3):420, 600-1.
29: von Bernuth H, Picard C, Jin Z, Pankla R, Xiao H, Ku CL, Chrabieh M, Mustapha IB, Ghandil P, Camcioglu Y, Vasconcelos J, Sirvent N, Guedes M, Vitor AB, Herrero-Mata MJ, Aróstegui JI, Rodrigo C, Alsina L, Ruiz-Ortiz E, Juan M, Fortuny C, Yagüe J, Antón J, Pascal M, Chang HH, Janniere L, Rose Y, Garty BZ, Chapel H, Issekutz A, Maródi L, Rodriguez-Gallego C, Banchereau J, Abel L, Li X, Chaussabel D, Puel A, Casanova JL. Pyogenic bacterial infections in humans with MyD88 deficiency. Science. 2008 Aug 1;321(5889):691-6.
30: de Carpi JM, Castejón E, Masiques L, Vilar P, Antón J, Varea V.
Gastrointestinal involvement in pediatric polyarteritis nodosa. J Pediatr
Gastroenterol Nutr. 2007 Feb;44(2):274-8.
31: Mou SS, Punaro L, Antón J, Luckett PM. Severe systemic hypersensitivity
reaction to ibuprofen: a presentation of systemic lupus erythematosus. J
Rheumatol. 2006 Jan;33(1):171-2.
32: Ozen S, Anton J, Arisoy N, Bakkaloglu A, Besbas N, Brogan P, García-Consuegra J, Dolezalova P, Dressler F, Duzova A, Ferriani VP, Hilário MO, Ibáñez-Rubio M, Kasapcopur O, Kuis W, Lehman TJ, Nemcova D, Nielsen S, Oliveira SK, Schikler K, Sztajnbok F, Terreri MT, Zulian F, Woo P. Juvenile polyarteritis: results of a multicenter survey of 110 children. J Pediatr. 2004 Oct;145(4):517-22.
Estudio multicéntrico, aleatorizado, de grupos paralelos, controlado con placebo, doble ciego para evaluar la seguridad, eficacia y farmacocinética de belimumab, un anticuerpo monoclonal humano anti-BLyS, más terapia estándar en pacientes pediátricos con lupus eritematoso sistémico (LES)
Promotor: GlaxoSmithKline S.A.
Código del protocolo: BEL114055
Función: Investigador Principal
“Estudio fase III, multicéntrico, abierto, para evaluar la farmacocinética, eficacia y seguridad de abatacept administrado por vía subcutánea (s.c.) en niños y adolescentes con artritis idiopática juvenil poliarticular (AIJp) activa y respuesta inadecuada (RI) a fármacos antirreumáticos modificadores de enfermedad (FAME) biológicos o no biológicos”
Promotor: Bristol- Myers-Squibb
Códigodel protocolo: IM101-301
Función: Investigador Principal
“Estudio de fase Ib, multicéntrico, abierto, para investigar la farmacocinética, farmacodinamia y seguridad de tocilizumab tras administración subcutánea a pacientes con artritis idiopática juvenil poliarticular”
Promotor: Roche
Código del protocolo: WA28117
Función: Investigador Principal
SHARE: Single Hub and access point for Paediatric Rheumatology in Europe
Entidad financiadora: SANCO 2011, section 3.2.3.3, FP7 call 2011 Second Programme of Community action in the field of Health (2008-2013). Executive Agency for Health and Consumers, EAHC (European Union)
Duración: 2012-2015
Financiación (en miles de euros): 860.244 euros
Investigador: colaborador
Incidencia de mutaciones somáticas del gen NLRP3 en pacientes con diagnóstico clínico compatible con síndromes periódicos asociados a la criopirina
Función: Investigador Principal
Agencia financiadora: Beca Sociedad Catalana de Reumatología
Financiación: 6000 euros
Duración: Junio 2012-Junio 2014
EPOCA (EPidemiology, treatment and Outcome of Childhood Arthritis)
Función: Investigador Principal Hospital Sant Joan de Déu
Agencia financiadora: PRINTO (Pediatric Rheumatology Trials Organization)
Duración: 2011-2014
Evaluation of Early Treatment in Children With Juvenile Idiopathic Arthritis: A Retrospective Analysis
Función: Investigador Principal
Agencia Financiadora: Pfizer
Financiación: 55.413 €
Duración: 2011-2013
PHARMACHILD – Long-term PHARMacovigilance for Adverse effects in Childhood arthritis focussing on Immune modulatory drugs a Pediatric Rheumatology Trials Organization (PRINTO) / Pediatric Rheumatology European Society (PRES) registry
Función: Investigador Principal Hospital Sant Joan de Déu
Agencia Financiadora: FP7- HEALTH-2010-single-stage. EU grant (2011-2014): (project number 260353)
Financiación: 3.920.000 € (2.970.000€ funded by FP7)
Duración: 2011-2014 (36 months)
Study CACZ885G2305. A randomized , double blind, placebo controlled, single-dose study to assess the initial efficacy of canakinumab (ACZ885) with respect to the adapted ACR pediatric 30 criteria in patients with Systemic Juvenil Idiopathic Arthritis(SJIA) and active systemic manifestations.
Financiación: Novartis.
Investigador: Principal
Duración: 2009-2010
Study CACZ885G2301. A randomized, double-blind, placebo controlled, withdrawal study of flare prevention of canakinumab (ACZ885) in patients with Systemic Juvenile Idiopathic Arthritis (SJIA) and active systemic manifestations.
Financiación: Novartis.
Investigador: Principal
Duración: 2009-2010
Study CACZ885G2301E1. An open label study of canakinumab (ACZ885) in patients with Systemic Juvenile idiopathic arthritis (SJIA) and active systemic manifestations.
Financiación: Novartis.
Investigador: Principal
Duración: 2009-2012
CLIPPER. A 2-Part Open-Label Study to Assess the Clinical Benefit and Long-term Safety of Etanercept in Children and Adolescents with Extended Oligoarticular Juvenile Idiopathic Arthritis, Enthesitis-Related Arthritis, or Psoriatic Arthritis.
Financiación: Wyeth- Pfizer.
Investigador: Principal
Duración: 2010-2012
STRIVE. Long-term, Multi-center, Longitudinal Post-marketing, Observational Registry to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children with Moderate to Severe Active Polyarticular or Polyarticular Course Juvenile Idiopathic Arthritis (JIA)
Financiación: Abbott.
Investigador: Principal
Duración: 2010-2020
Estudio piloto, abierto, multicéntrico, de eficacia y seguridad del tratamiento con canakinumab duranet 6 meses y seguimiento de hasta 6 meses, en pacientes con síndrome Hiper-IgD activo.
Financiación: Novartis.
Investigador: Principal
Duración: 2011-2012.
INternational CHildhood ARthritis GEntics (INCHARGE) Consortium: A Genome Wide Association Study of Childhood Arthritis.
Función: Investigador Principal Hospital Sant Joan de Déu
Agencia financiadora: Arthritis Research campaign: ARC grant reference 17552.
Duración: 2008-(sin limite en la actualidad)
Número de Proyecto: PI06/0241
The PRES European Network of Registries for Autoinflammatory Diseases in childhood: EuroFever Project
Función: Investigador principal Hospital Sant Joan de Déu
Agencia Financiadora: Agency for Health and Cosnumers EAHC, Project Nº 2007332)
Financiación: 341.733,46 €
Duración: 2008-2011(36 meses)
Estudio de correlación entre los factores clínicos y polimorfismos genéticos para el desarrollo y severidad de la uveítis asociada a la artritis idiopática juvenil (AIJ).
Función: Investigador Principal Hospital Sant Joan de Déu
Agencia financiadora: Hospital Clinic – Hospital Sant Joan de Déu
Duración: 2008-2011
Phase III. A Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel Group Study of One year Duration Followed by 2 Years of Open-label Treatment to Determine the Safety and Efficacy of Orally Administered 2.5 mg or 5.0 mg Daily Risedronate (risedronate sodium), in Children > 4 to < 16 Years Old with Osteogenesis Imperfecta. 2006
Función: Investigador Principal Hospital Sant Joan de Déu
Agencia Financiadora: Warner Chilcott – Procter and Gamble – Sanofi-Aventis
Duración: 3 años (2006-2010)
Cross cultural validation of a novel quality of life scale for pediatric lupus – proposal and update
Función: Investigador Principal Hospital Sant Joan de Déu
Agencia Financiadora: UMDNJ Foundation Grant 2004-2005; Pfizer Clinical Scholar Research Award 2005-2007; Arthritis Foundation Investigator Award 2007-2009; CARRA
Duración: 4 años (2006-2009)
Número de Proyecto: PS09/01182
Título: Análisis de las vías de señalización Toll/IL-1 receptor (TIR), Nod-like receptor (NLR) y NF-κB en las formas hereditarias y no hereditarias de las enfermedades autoinflamatorias. Valoración de su utilidad clínica como pruebas predictivas de respuesta a terapias biológicas.
Entidad financiadora: Fondo de Investigaciones Sanitarias
Duración: 2010-2012
Centro: Hospital Clínic de Barcelona – Hospital Sant Joan de Déu
Investigador principal: Jordi Yagüe Ribes
Investigador: Colaborador
Phase III. A Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel Group Study of One year Duration Followed by 2 Years of Open-label Treatment to Determine the Safety and Efficacy of Orally Administered 2.5 mg or 5.0 mg Daily Risedronate (risedronate sodium), in Children > 4 to < 16 Years Old with Osteogenesis Imperfecta. 2006
Obejtivos: Valoración de la seguridad y eficacia del tratamiento con risedronatoen pacientes con Osteiogénesis Imperfecta
Finaciación: Industria farmaceutica
Centro: Multicéntrico Internacional
Investigador: colaborador
Duración: 3 años (2006-2010)
Número de Proyecto: PI06/0241
Título: Análisis de las bases moleculares responsables de las enfermedades autoinflamatorias sistémicas no filiadas: desarrollo y validación de pruebas diagnósticas e identificación de potenciales dianas para terapias biológicas inmunomoduladoras.
Entidad financiadora: Fondo de Investigaciones Sanitarias
Duración: 2007-2009
Centro: Hospital Clínic de Barcelona – Hospital Sant Joan de Déu
Investigador principal: Jordi Yagüe Ribes
Investigador: Colaborador
Cross cultural validation of a novel quality of life scale for pediatric lupus – proposal and update
Objetivos: validación de una escala clínica para la valoración de la calidad de vida en pacientes con Lupus
Financiación: No
Centro: Multicéntrico Internacional
Investigador: colaborador
Duración: 4 años (2006-2009)
A randomised trial of 6 months versus 12 months withdrawal of methotrexate (MTX) in patients with juvenile idiopathic arthritis (JIA) in clinical remission
Objetivos: Valorar la duración de la remisión clínica tras la retirada del metotrexate a los 6 meses o a los 12 meses en pacientes con Artritis Idiopática Juvenil
Financiación: PRINTO (Pediatric Rheumatology Trials Organization)
Centro: Multicéntrico Internacional
Investigador: Colaborador
Duración: 3 años (2006-2008)
Artritis inflamatòries de la infància: estudi prospectiu de la seva incidència i prevalença a Catalunya
Objetivo principal: Conocer la incidencia y prevalencia de las artritis inflamatorias en la infancia en Catalunya
Finaciación: Beca Marató de TV3
Centro: Hospital Vall d’Hebron – Hospital Sant Joan de Déu
Investigador: Colaborador
Duración: 3 años (2004-2007)
Inception cohort for early juvenile systemic sclerosis
Objetivos: Creation of a minimal gold standard for avalauation of patients with juvenile systemic sclerosis
Financiación. No
Centro: Multicéntrico internacional
Investigador: Colaborador
Date full C.V. last updated: August 29th 2014
This abridged C.V. represents an accurate summary of my current C.V.
Signature of Investigator Date: August 29th 2014
Shai Ashkenazi, Israel
Tel Aviv University
Shai Ashkenazi completed his medical education and residency in pediatrics in Israel and a fellowship in pediatric infectious diseases in Houston, Texas, USA (1987-90). He is currently Professor of Pediatrics and Incumbent of the Lea and Arieh Pickel Chair for Pediatric Research at the Sackler Faculty of Medicine, Tel Aviv University; Chairman of the Department of Pediatrics A at Schneider Children’s Medical Center; Head of the Research Laboratory for Pediatric Infectious Disease at the Felsenstein Medical Research Center, Chairman of the Israeli Scientific Council, Chair of the Education Committee of the European Society for Paediatric Infectious Diseases, member of the Scientific Committee of the World Society for Pediatric Infectious Diseases, and member of the National Council for Child Health.
Dr Ashkenazi is a member of the Editorial Boards of several national and international medical journals, a co-author of over 200 medical publications and over 30 chapters in books and the Editor of the Hebrew Textbook of Pediatrics (8 editions). He has received dozens of research grants, including from the NIH (USA), European Union, Chief Scientist and the BSF.
Sami Bahna, USA
LSU Health Sciences Center
Prof. Sami L. Bahna is professor of pediatrics and medicine and chief of the Allergy/Immunology Section at Louisiana State University School of Medicine in Shreveport, Louisiana. He graduated and completed his PhD in Egypt. He serves on numerous international committees and has received multiple distinguished awards. He has been an invited speaker to many international scientific meetings. Dr. Bahna served on several NIH committees and three terms on the Executive Committee of the AAP-Section on Allergy & Immunology. He is author or co-author of more than 270 publications and he is frequently invited as visiting professor at major institutions and speaker at major national and international meetings.
Ami Ballin, Israel
Tel Aviv University
Dr. Ami Ballin
Graduated from the Sackler School of Medicine, Tel-Aviv University (1976) and is board certified in Pediatrics, Hematology and Pediatric Hemato-oncology. He did a fellowship at the Hospital for Sick Children (1985-1987) and currently is the head of the Pediatrics department at the E. Wolfson Medical Center, Israel.
Dr. Ballin is Professor in Pediatrics and vice-Dean of the Sackler School of Medicine. He is the chairman of the Committee of Professionalism at the Sackler School of Medicine. Dr. Ballin was the medical director of the Israeli National Umbilical Cord Blood Bank and formerly the chairman of the Israeli Clinical Pediatric Society.
Itai Berger, Israel
Hadassah Medical Center
Dr. Itai Berger
Education:
M.D. 1985-1992, Ben-Gurion University of the Negev,Faculty of Health Sciences, Beer-Sheva, Israel
Postgraduate Training
1992-1993: Internship, Shaare Zedek Medical Center,Jerusalem
1993-1998: Residency in Pediatrics, Department of Pediatrics, Shaare Zedek Medical Center, Jerusalem
1998-2003: Pediatric Neurology Fellowship, Department of Neurology, Children’s National Medical Center, Washington DC, USA and Neuropediatric Unit, Shaare Zedek Medical Center, Jerusalem
2003- 2005: Senior neurologist, Neuropediatric Unit,Shaare Zedek Medical Center, Jerusalem
2005-present: Senior neurologist, Neuropediatric Unit,Hadassah-Hebrew University Medical Center,
Academic Appointments:
2005 – Lecturer in Pediatrics, Ben-Gurion University of the Negev, Faculty of Health Sciences, Beer-Sheva,Israel
2007 – Lecturer, The Hebrew University of Jerusalem, Faculty of Medicine
Research Topics:
Neonatal EEG
The Biological aspect of selective mutism.
Molecular basis of lipoamide dehydrogenase deficiency in Ashkenazi Jews.
Clinical experience with open label topiramate use in infants younger than 2 years.
Third ventricle enlargement among newborn infants with trisomy 21.
Mitochondrial complex I deficiency caused by a deleterious NDUFA11 mutation.
Prenatal microcephaly.
The effect of anti-epileptic drugs on mitochondrial activity.
Novel computerized test: an objective measures of Attention-Deficit/Hyperactivity Disorder.
The genetic basis of aromatic L-amino acid decarboxylase (AADC) deficiency.
Body mass index of children with Attention-Deficit/Hyperactivity Disorder.
The impact of fetal mild isolated ventriculomegaly on speech and language development.
Neonatal seizures recognition – comparative study of continuous amplitude integrated EEG versus conventional EEG.
The unique neurodevelopment of extremely low-birth weight infants.
Xavier Bosch, Spain
Health University Barcelona Camus
Dr. F. Xavier Bosch conducts epidemiological research on cancers linked to infectious agents notably on cancer of the liver, of the cervix, of the skin, of the vagina, of the anus, of the penis and of the oral cavity. He has also carried on research studies on diet and colorectal cancer and led a program of implementation and methodological research in cancer registration.
These various research projects have been instrumental in demonstrating the causal role of Human Papilloma Virus (HPV) in cervical cancer and on the opportunities for liver cancer prevention using Hepatitis B Virus (HBV) vaccines in rural Africa. Some of these studies have played a catalytic role for the initiation of the first vaccine trials for HBV and HPV and for the evaluation of HPV tests as screening tools. Dr. F. Xavier Bosch has worked in what is now called molecular epidemiology. His research work has been characterized by the integration of the latest biological assays to determine exposure to carcinogens with epidemiological field studies carried out in about 35 countries around the world, particularly in Spain, Latin America, Africa and Asia. The final goal of his research has been the application of the aetiological knowledge derived from it, to the primary prevention of cancer.
Xavier Castellsague, Spain
Catalan Institute of Oncology
Dr. Xavier Castellsagué , MD, MPH, Ph.D academic background includes a Medical degree (University of Barcelona, Catalonia, 1983), a specialization in Preventive Medicine and Public Health (Ministry of Education and Science, Spanish Government 2003), a Master of Public Health degree (Yale University, CT, USA 1987), and a Ph.D. in Epidemiology and Public Health (Yale University, CT, USA 1991). His doctoral thesis, “Tubal sterilization, intrauterine contraception and the risk of endometrial cancer”, examined the association between tubal ligation and IUD use on the risk of developing endometrial cancer. Between 1991 and 1992 he worked as a post- doctoral fellow at the International Agency for Research on Cancer (IARC/WHO, Lyon, France). Since 1992 he has been a Senior Epidemiologist and Section Chief at the Unit of Infections and Cancer (Cancer Epidemiology Research Program) at the Institut Català d’Oncologia (ICO) in Hospitalet de Llobregat, Barcelona (Catalonia).
Since 1987, Dr. Castellsagué´s main research interests focus on the descriptive and etiological epidemiology of Human Papillomavirus (HPV) in ano-genital, esophageal, and oropharyngeal cancers both in men and women. He has been involved in many national and international epidemiologic studies on HPV and cancer. In the last 10 years he has been actively participating in the clinical programs of prophylactic and therapeutical vaccines against HPV and cervical cancer. He has been the principal investigator of five phase II-III clinical trials on HPV vaccination: two trials testing the quadrivalent vaccine against HPV 6/11/16/18 infections, one trial testing the bivalent vaccine against HPV 16/18 infections, and three other trials testing the new generation of polyvalent HPV vaccines. These investigations are revolutionizing current strategies for the prevention of HPV-related cancers and diseases and they may be regarded as one of the most important advances ever made on cancer prevention.
Dr. Castellsagué is currently author or co-author of 207 peer-reviewed scientific publications with impact factor, including top scientific journals such as the New England Journal of Medicine, The Lancet, and the Journal of the National Cancer Institute. He has presented results and scientific communications at more than 400 conferences and symposiums. His most prominent contributions include the identification of the protective effects of male circumcision on the risk of penile HPV infection and of cervical cancer in men’s female partners and the risk reduction of cervical cancer linked to IUD use.
Dr. Castellsagué has taught at IARC and in postgraduate courses of different national and international programs. Currently, he is Professor of a virtual training course on cancer research methodologies included in the “e-Oncologia” project, an extensive international “e-learning” program run by the Catalan Institute of Oncology in collaboration with various teaching institutions.
Dr. Castellsagué is an editor of the “HPV Today” newsletter, a publication that is translated in 5 languages and aims at informing the medical community on the important research advances on HPV and cancer.
Dr. Castellsagué is also the Director of the ICO/IARC Information Centre on HPV and Cancer, which gathers and disseminates information on HPV and related cancers for each of the countries and regions in the World with the aim of accelerating the implementation of preventative strategies to reduce the burden of cervical cancer and other HPV-related diseases in the World.
Helen Chan, Hong Kong
University of Chinese Medicine
Rolando Cimaz, Italy
University of Florence
Cimaz Rolando Born in Milan, Italy, November 21st 1961Graduated in Medicine and Surgery Magna Cum Laude from Università degli Studi di Milano on July 20th, 1987Specialized in Pediatrics from the University of Milano in July 1991Specialized in Rheumatology from the University of Milano in November 2003
Medical intern from 1984 at the First Pediatric Dpt of University of Milano
Qualified to practice Medicine in USA (Foreign Medical Graduates Examination in the Medical Sciences);
Clinical Fellow (September 93 to September ‘94) in Pediatric Rheumatology at The University of Texas Southwestern Medical School, Dallas, Tx, USA (Prof CW Fink)
Worked at the Clinica Pediatrica G e D De Marchi of Milano University, 1995-2005
Visitor, Prof BM Ansell, UK, June 1998
Visiting Professor, University of Lubiana, 1999
Visiting Professor, University of British Columbia (prof R Petty, July, August 2000)
Executive committee member and cofounder, Pediatric Rheumatology European Society
Maitre des Conferences- Praticien Hospitalier. Universitè Lyon 1- Hospices Civiles de Lyon, Lyon, France, 2005-2006
Dirigente Medico (dal 1 Marzo 2007) and Professore Associato Università di Firenze (dal 1-12-2007), Osp. Meyer Firenze
Ashish Desai, UK
King’s College Hospital
Dr. Ashish P Desai completed his training in paediatric surgery in India. He then obtained his FRCS (Paediatric Surgery).
He is a Consultant Paediatric Surgeon at King’s College Hospital, London. He has established the surgical weight loss centre for Adolescents at the hospital. He routinely performs Gastric Band and Sleeve Gastrectomy.
He has been a part of numerous national committees and has been working towards establishing adolescent bariatric surgery standards in the country.
He has written numerous academic articles and chapters both on bariatric surgery as well as general paediatric surgery. He has been invited speaker in many international and national meetings.
Despina Eleftheriou, UK
University College London
Dr. Despina Eleftheriou
Paediatric Rheumatology, Great Ormond Street Hospital for Children NHS Foundation Trust
PRESENT APPOINTMENT:
Senior Lecturer and Honorary Consultant Paediatric Rheumatologist, ARUK centre for adolescent rheumatology, Institute of Child Health and Great Ormond Street Hospital for Children NHS Foundation Trust (6PAs clinical/4PAs research)
EDUCATION/QUALIFICATIONS:
- 1994 A level equivalent (9 in total with distinction) 3rd Mytilene High School, Greece
- 2000 MB BS National and Capodistrian University Medical School, Athens, Greece
- 2008 MRCPCH The Royal College of Paediatrics and Child Health, London
- 2012 PhD UCL Institute of Child Health
PROFESSIONAL HISTORY:
- 2012-2013 Consultant in paediatric rheumatology Great Ormond Street Hospital NHS Trust, London
- 2009-2012 AMR Clinical Research Fellow and Honorary Consultant in paediatric rheumatology UCL Institute of Child Health and Great Ormond Street Hospital NHS Trust
- 2008-2009 Locum consultant in paediatric rheumatology Great Ormond Street Hospital NHS Trust, London
- 2007-2008 Barbara Ansell Clinical Research Fellow and Honorary Specialist Registrar in paediatric rheumatology UCL Institute of Child Health and Great Ormond Street Hospital NHS Trust
- 2006-2007 Specialist registrar (LAS) in paediatric rheumatology Great Ormond Street Hospital NHS Trust, London
- 2005-2006 Registrar in paediatric oncology Royal Marsden Hospital, London
- 2004-2005 Registrar in paediatric Infectious Disease, PICU and neurology St Georges Hospital NHS Trust, London
- 2003-2004 SHO in Paediatrics/Neonate St Helier’s Hospital NHS Trust, London
- 2002-2003 SHO in Paediatrics/Neonates St Peter’s Hospital NHS Trust, Chertsey, Surrey
- 2001-2002 SHO in paediatrics Agia Sophia Children’s Hospital, Athens, Greece
- 2000-2001 HO in general surgery, internal medicine, paediatrics Limnos Hospital, Limnos, Greece
Ellis Hon, Hong Kong
The Chinese University of Hong Kong
Dr. Ellis Hon is a paediatric professor at the Chinese University of Hong Kong. He received undergraduate medical education at the University of Western Australia. He is a Fellow of the American Academy of Pediatricians (FAAP) and Fellow of Critical Care Medicine (FCCM). His Doctor of Medicine (MD) thesis is on the assessment of eczema. He has published more than 250 peer-reviewed scientific papers, books and book chapters; and his research interests include many paediatric issues. He has performed extensive research on topical emollients, antibiotic, corticosteroid, systemic immunotherapy, food avoidance and dietary supplementation, traditional Chinese medicine and bench research on eczema biomarkers, as well as many paediatric critical care issues (including SARS, respiratory infections, poisoning and injuries). Dr Hon is particular keen to education parents to dismiss a lot of myths and fallacies that hinder good child health in common allergic diseases.
Warren Hyer, UK
St. Mark’s Hospital
Dr. Warren Hyer
Consultant Paediatric gastroenterologist at St Mark’s Hospital UK, and Chelsea and Westminster Hospital. 20 years of general and specialist paediatrics working in a large international respected referral centre. Expertise in polyposis work with published papers related to paediatric polyposis. Expertise in food allergy, nutrition, and general gastroenterology. Lectures nationally and internationally on general gastroenterology issues including abdominal pain, rectal bleeding, paediatric emergencies, food allergy.
His lectures involve audience participation basing his lectures on case studies and evidence based treatment, mixed with personal practice.
Previous posts include time spent as a paediatric consultant at Royal Childrens Hospital , Melbourne 2007.
Mireia Jane, Spain
Catalan Public Health Agency
Dr. Mireia Jane is Medical Doctor and Public Health and Preventive Medicine Specialist (Universitat de Barcelona). She holds a PhD in Medicine by the Universitat Autònoma de Barcelona, a Master of Science by the University of London and a Diploma in Public Health by the London School of Hygiene and Tropical Medicine.At present she is Deputy Director of Public Health Surveillance and Emergency Response Department at the Catalan Public Health Agency. Its main lines of work are related to communicable diseases monitoring and rapid response to public health alerts. She is also member of the Catalan Vaccination Assessing Committee and at present collaborates in the European Pertinent Project “Setting up a sentinel system to assess the burden of whooping cough in EU/EEA”.In addition to the surveillance and control of infectious diseases, one of other main areas of work is the surveillance of perinatal indicators, with especial interest in prematurity, through the newborns registry and the Catalan Obstetric Surveillance System (CATOSS). The department is also a collaborating member of the Euro-Peristat.
Previously, she was the Head of the Mother and Child Health Unit at the Catalan Public Health Agency, leading, as an epidemiologist, the maternal public health field for more than 10 years. Earlier, she was awarded a Research Fellowship by the Fitzwilliam College of the University of Cambridge and also worked at the Municipal Institute of public Health in Barcelona.
Dr Jané has been member of PhD thesis committees and director of PhDs programme. She collaborates in MSc Diploma Public Health courses at the Pompeu Fabra University. She has published in impact factor journals and coordinated public health books and technical reports.
Bertrand Jordan, France
CoReBio PACA
Prof. Bertrand Jordan
CNRS Emerituhys Research Director (ret.)
CoReBio PACA (coordination of core facilities in the French South-East)
Career outline:
1965: PhD in particle physics at CERN, Geneva;1967-1972: Studies on ribosomal RNA structure in E. coli and Drosophila; 1978-1979: Sabbatical at Imperial College, London; 1980 Marseille-Luminy INSERM/CNRS Immunology Centre (CIML), first isolation and complete sequence of an HLA gene.
From 1986 onwards: Human molecular genetics; large scale mapping in Xq27 and Xq28 and microdissection of Fragile X. 1991: International Study on the state of the art in Human Genome Research, based on visits to key labs in major countries (USA, Japan, Great Britain…); this study has been published in book form in French, English, Japanese and Portuguese. 1992-1999: New research group at CIML, Marseille, interfacing genome research and immunological questions through large-scale expression measurement using DNA arrays. Development of DNA array and microarray technology (more than 30 publications in this field since 1995). 2000-2002: founder and coordinator of the Marseille-Génopole genomics consortium.
From 2003: Advisor to Marseille-Nice Genopole.
From 2009: Advisor to CoReBio PACA (coordination of core facilities in the French SouthEast), and in addition.
From 2013: Associate Scientist, ADES, Marseille Medical School.
Present position, activities and interests:
Academic: Emeritus Research Director (retired), Counsellor for CoReBio PACA (coordination of core facilities). Editorial Board of Médecine/Sciences and of Science et pseudo-sciences. Member of the scientific committee of the Chinese National Research Programme for Biopharmaceuticals (Taiwan)
Industrial: Occasional consultant for Génopole-Industrie (Technology transfer for the Evry Genopole), BioAm, LCF Rotschild (risk capital investors), Immunotech, FUJI film (instrumentation division) and Phalanx (Taiwan). Member of the Scientific advisory board and permanent consultant for PamGene (Netherlands) and Dr. Chip (Taïwan); permanent consultant for Halio Dx (Marseille). President of the Scientific Committee of Coral Biome (Marseille).
Iolanda Jordan, Spain
Barcelona University
Dr. Iolanda Jordan
WORK EXPERIENCE
Staff of Intensive Care Medicine Service, H Sant Joan de Déu, Barcelona, Spain, from since 2002.
Professor at School of Medicine, Barcelona University, Paediatric Department, since 2008.
Professor at School of Nurses, Barcelona University, since 2005.
Staff of Emergency Care Service, H Sant joan de Déu, from 1999 to 2002
Staff of Public Sanitary Transport Team, form 1999 to 2004.
Vice-presidency and Scientific presidency of Pediatric Catalonian Society, since 2011. https://www.scpediatria.cat
Coordinator of the Working Groups of the Spanish Society of Paediatric Intensive Care Medicine, since 2010. https://www.secip.com. Coordinator of the Infectious Disease in Intensive Care Medicine from Spanish Society of Paediatric Intensive Care Medicine, from 2007 to 2011.
Member of The Human Investigation Committee, Institutional Review Board of Hospital Sant Joan de Déu, since 2012.
EDUCATION AND TRAINING
Medicine and General Surgery degree. Hospital Clínic i Provincial, Barcelona, Bacelona University, 1988-1994 Qualification: excellent.
Doctor in Medicine, by Barcelona University, June 2004. Qualification Excellent, cum laude.
Medical Specialization by MIR (Resident Intern physician) training, of the Spanish Ministry of Health, with place number 99. Paediatric specialization training at Hospital Clinic and H Sant Joan de Déu, Barcelona, Spain.
Replace with EQF (or other) level if relevant
Assistance to different kind of medical courses (more than 60), at national and international level, in relation with my personal preferences (pediatric, intensive care, infectious diseases).
Gideon Koren, Canada
Hospital for Sick Children
Gideon Koren, MD, FRCPC is the founder and director of the Motherisk Program and professor of Paediatrics, Pharmacology, Pharmacy, and Medical Genetics at the University of Toronto.
Author of 1300 peer review scientific papers and editor of over a dozen medical books, Dr. Koren is one of very few Canadian physician-scientists whose career is dedicated to drug safety, the molecular mechanisms and clinical effects of adverse drug and chemical reactions, with specific focus on pregnancy and children.
Dr. Koren has received numerous national and international awards for his work on drug safety. He served as the Chair of the NIH review panel for Obstetric Pharmacology Research Units, and The Hospital for Sick Children’s Foundation Scientific panel on paediatric Complementary and Alternative Medicine. In 2000 Dr. Koren established the Canadian Research Network for Fetal Alcohol Syndrome (“FACE”–Fetal Alcohol Canadian Expertise). In 2002 he created the peer review medical journal Fetal Alcohol Research. Dr. Koren also serves as a paid consultant to Duchesnay.
Zohar Landau, Israel
Wolfson Medical Center
Dr. Zohar Landau Graduated from the Technion, Israel Institute of Technology, Faculty of Medicine, Haifa, Israel (1993) and is board certified in Pediatrics and Pediatric Endocrinology. Dr. Landau spent a year in a fellowship program in Translational Medicine. She is the head of the Pediatric Endocrinology Unit at E. Wolfson Medical Center. Dr. Landau founded the first multidisciplinary bariatric surgery program for children in Israel. Her research focuses mainly on different aspects of type 1 diabetes mellitus and obesity. Dr. Landau is a senior lecturer at the Department of Pediatrics at the Sackler School of Medicine, Tel Aviv University.
Angeli Landeros, USA
Yale University School of Medicine
Dr. Angeli Landeros
Education:
M.D. La Salle University, Mexico City, 2000
Career/Academic Appointments:
1995-2000 Medical School La Salle University Mexico City
2000-2001 Social Service in Otatitlan, Veracruz Mexico
2002-2006 Psychiatric Residency at the Hospital Espaniol de Mexico/Universidad Nacional Autonoma de Mexico
2006-2009 Post-doctoral research fellow, Yale Child Study Center, Program for Minority
Research Training in Psychiatry /APIRE/NIMH
2006-2015 On-going collaboration with Drs. Lisanby and Mantovani from Columbia University on rTMS “Treatment project for adults with severe Tourette Syndrome”.
2009-2011 Post-doctoral research fellow, Yale Child Study Center
2012-present Associate Research Scientist, Yale Child Study Center
Board Certification:
Associacion Mexicana de Psiquiatria 2006-present
Professional Honors & Recognition:
2006-2008:
ACNP Young Investigator Travel Award, American College of Neuropsychopharmacology
Departmental Committees:
2006-present
Interview Tutor and/or Write-up tutor for the 3rd year medical students, through the Department of Psychiatry, Yale School of Medicine
Dorit Lev, Israel
Wolfson Medical Center
Dr. Dorit Lev is the Director of the Genetic Institute and the Co-Director of the Metabolic- Neuro-Genetic (Magen) service at the Wolfson Medical Center, Israel. In addition, Dr. Lev is a senior lecturer at the Department of Paediatrics at the Sackler School of Medicine, Tel Aviv University.
Her research focuses mainly on the delineation and identification of genes causing neurogenetic diseases and neuromuscular disorders and other genetic conditions, especially mitochondrial disorders.
Dr Dorit Lev is also a senior lecturer at the Department of Pediatrics at the Sackler School of Medicine, Tel Aviv University.
She has been involved in carrying out clinical and molecular research mainly in the following fields: Delineation of new neurogenetic, neuromuscular syndromes, mitochondrial disorders and neurogenetic fetal abnormalities.
Manuel Sanchez Luna, SPAIN
hospital general universitario
Dr. Manuel Sanchez Luna
Title: Medical Director of the Neonatology Division and NICU at HOSPITAL GENERAL UNIVERSITARIO “GREGORIO MARAÑON”
Madrid (SPAIN).
Medical License Acquired: 07.12.1982. Complutense University, Madrid.
School of Medicine: 1976-77 to 1981-82. Complutense University, Madrid.
Residence in Pediatrics: 1984-89. Hospital Universitario “La Paz”. Madrid
PhD, MD grade in Pediatrics.
Medical Thesis on PPHN and mechanical ventilation 1991-1994.
Accredited Associate Professor in Pediatrics: Complutense University of Madrid
Type of Practice: Fulltime National University Hospital. Since: 1989.
Fields of Specialization: Neonatology.
Areas of Interest: Bronchopulmonary Dysplasia, Respiratory physiology, Sepsis, Shock, personalized nutrition
Hospital type: Public Academic Hospital, Complutense University of Madrid. Level IIIc national reference center. 6.000 deliveries per year.
Professional Career & Clinical Research Experience: Hospital General de Móstoles, from 1989 to 1991. Hospital Materno-Infantil Gregorio Marañón from 1991- actual.
Head of Section of NICU, Hospital Materno-Infantil Gregorio Marañón, from 2001-2013.
Medical Director of the Neonatology Division and NICU from August 2013.
Animal Research in PPHN, Septic shock, mechanical ventilation, HFOV and iNO. 4 National Grants (FIS) Principal Investigator, from 1984-1992. Hospital Universitario La Paz. Madrid.
Animal Research in lung transplantation, ECMO and immature lung . 2 National Grants (FIS) as PI From 1992 –actual. Animal Research Congenital Diaphragmatic Hernia Grant National grants 2006. Clinical research, neonatal lung physiology, surfactant deficiency, ECMO from 1991, Clinical Research in Decision Making Analysis 2 Grants from 1999 to 2002. 5 Multicenter Randomized controlled Trials as, PI from 1996. Hospital Materno-Infantil Gregorio Marañón
Conferences, Chairs, at international and national Congress and workshops: more than 200
Publications in National and International scientific journals and books: >100
Others:
Member of the ESPR, ESICM, ESPNIC, ESN, UENPS
President of the Union of European Neonatal and Perinatal Societies, UENPS.
Vice-President of the World Association of Perinatal Medicine, WAPM
Elected President of the International Neonatology Association, INA
MBA in Medical Governance and Hospital Administration
Sheela Magge, USA
The George Washington University
Prof. Sheela Magge, M.D., M.S.C.E.
Education:
1988 – 1989
Massachusetts Institute of Technology
Cambridge, MA. Biology major. G.P.A.: 5.00. (M.I.T. equivalent to national rating of 4.00)
1989 – 1992
Harvard University
Cambridge, MA. A.B., Biochemical Sciences, Cum Laude. Transferred from M.I.T. after freshman year in order to obtain a liberal arts background, while still majoring in biochemistry.
1993 – 1998
Yale University School of Medicine
New Haven, CT. M.D. Included extra year spent on research and clinical work abroad.
2002 – 2006
University of Pennsylvania Center for Clinical Epidemiology and Biostatistics
Philadelphia, PA. M.S.C.E. (Masters of Science in Clinical Epidemiology), December, 2006.
1998 – 2001 Boston Combined Residency Program in Pediatrics – Internship and Residency, Children’s Hospital, Boston, MA.
2001 – 2004 The Children’s Hospital of Philadelphia, Division of Endocrinology Fellowship training in pediatric endocrinology.
2002 – 2005 Postdoctoral Fellow (Juvenile Diabetes Research Foundation – Lawson Wilkins Pediatric Endocrinology Society (JDRF-LWPES) fellowship), University of Pennsylvania School of Medicine, Philadelphia, PA
2005 – 2007 Postdoctoral Fellow (K12 Award in Diabetes Research), The Children’s Hospital of PhiladelphiaEmployment:
Faculty Appointments:
1998-2001
Instructor in Pediatrics, Harvard Medical School
2002-2007
Instructor in Pediatrics, University of Pennsylvania School of Medicine
2007-2014
Assistant Professor of Pediatrics, University of Pennsylvania School of Medicine
2014-present
Adjunct Assistant Professor of Pediatrics, University of Pennsylvania School of Medicine
2014-present
Associate Professor of Pediatrics, George Washington University School of Medicine and Health Sciences
Hospital and Administrative Appointments:
2004 – 2014 Attending Physician, Division of Endocrinology and Diabetes, The Children’s Hospital of Philadelphia
2012 – 2014 Attending Physician, The Healthy Weight Program, The Children’s Hospital of Philadelphia
2014- present Attending Physician, Division of Endocrinology and Diabetes, Children’s National Medical Center
2014- present Attending Physician, Improving Diet, Energy, and Activity for Life (IDEAL) Clinic, Children’s National Medical Center
Marina Markovic, Serbia
University of Belgrade
Marina Atanaskovic-Markovic is associate professor of pediatrics and allergy at School of Medicine, University of Belgrade. She works also at University Children’s Hospital of Belgrade. Her professional training consisted of a specialist training in pediatrics (University Children’s Hospital of Belgrade, 1994-1997), completed master’s (1996) and PhD (2001) thesis as well as finished sub-specialization in allergology and clinical immunology (2002) at School of Medicine, University of Belgrade. She has been considered a European Pediatric Allergologist according to the standards set by the Education and Training Committee-Pediatric Allergology and the Section on Pediatrics of the Europen Academy of Allergy and Clinical Immunology in 2007.She won the award for best young scientists of the republic of Serbia (2002).She has more than 200 publications on allergy and pediatrics, and her research output has been highly cited. She is invited to speak at major national and international meetings. She is a member of International and National societies such as EAACI (European Academy of Allergology and Clinical Immunology), ACAAI (American College of Allergy, Asthma and Immunology), BSACI (British Society for Allergy & Clinical Immunology), WAO (World Allergy Organization), ENDA (European Network for Drug Allergy, WONDA (World Network for Drug Allergy) and UAKI (Serbian Association of Allergologists and Clinical Immunologists).
She is a member of the editorial board of the student journal Medical Faculty of Medicine, University of Belgrade, and Ad hoc refer for jourmals such asPediatric Allergy and Clinical Immunology, Allergy, Clinical Drug Investigation, Expert Opinion on Drug Safety,International Journal of Immunopathology and Pharmacology, Adis International…..
Daphna Marom, Israel
Tel Aviv University
Dr. Daphna Marom,
EDUCATION
1989-1994 Hadassah Medical School, Hebrew University, Jerusalem, Israel.
2001 Board certified in Pediatrics.
Jan. 2008 Board certified in Human Medical Genetics.
FURTHER STUDIES
2004 Genzyme Gaucher disease training program, Boston, MA, USA.
2008 Good Clinical Practice (GCP). Performance of clinical trials and
Proper clinical practice course for physicians. Israel Medical Association, Ramat- Gan, Israel.
ACADEMIC AND PROFESSIONAL EXPERIENCE
1999 – Engaged in teaching of American and Israeli medical students during present clinical pediatric clerkship, including lectures, bedside teaching and
2014- Lecturer in Pediatrics, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
2015- Lecturer, Genomic Medicine course, 1st-year post-graduate medical students, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
2007 – Attending Pediatrician & Clinical Geneticist, Pediatric Ward A,
MEMBERSHIP IN PROFESSIONAL SOCIETIES
Israel Medical Association
Israeli Society for Clinical Pediatrics
Israel Ambulatory Pediatric Association
Israeli Society of Medical Genetics
European Society of Human Genetics
PUBLICATIONS
Over 20 publications in general pediatrics and clinical genetics.
Marc Michalsky, USA
The Ohio State University
Dr. Marc P. Michalsky is Professor of Clinical Surgery and Pediatrics at The Ohio State University College of Medicine and serves as Surgical Director for the Center for Healthy Weight and Nutrition at Nationwide Children’s Hospital – the first and only free-standing adolescent bariatric surgery center in the U.S. to be accredited by the American College of Surgeons Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program ( MBSAQIP).
As an MBSAQIP verified surgeon, Dr. Michalsky meets the highest standards of surgical quality and safety. He also conducts MBSAQIP site surveys on behalf of the American College of Surgeons. In addition, Dr. Michalsky serves as a clinical investigator on several National Institutes of Health (NIH)-sponsored research initiatives examining outcomes following surgical weight reduction in the severly obese adolescent population.
Dr. Michalsky’s team currently performs gastric sleeve surgery, gastric bypass surgery, and adjustable gastric banding on severely obese adolescents.
Fernando Moraga-Llop, Spain
Hospital Sant Joan de Déu Barcelona
Dr. Fernando Moraga-Llop
Position
Pediatrician of Hospital Universitari Vall d’Hebron, Staff of Pediatric Service. Retired.
Work experience
Knowledge Interest area: pediatrician, infectious diseases and vaccines.
Professor at School of Medicine, Autonoma University, Barcelona.
Professor at School of Nurses, Autonoma University, Barcelona.
Professor at Pediatric Infection Master, Autonoma University, Barcelona.
Member of Vaccine Experts Committee, from Sanitary Department of Generalitat de Catalunya (1995-2003).
Expert assessor in vaccines, from Sanitary Department of Generalitat de Catalunya since 2011.
Director of the “Infectious pathology in Pediatrics”, from Hospital Universitari Vall d´Hebron de Barcelona (21 editions, since 1991).
Director of the anual course “Vaccine actualization” from Hospital Universitari Vall d´Hebron de Barcelona (20 editions, since 1997).
III Congress from the Spanish Society of Infectology, president (2006).
President Catalonian Pediatric Society, since 2012. https://www.scpediatria.cat
Vicepresident of the Spanish Pediatric Society (2001-2004).
Vicepresident of the Spanish Association of Vaccinology, since 2009
Journal Direction: “Pediatria Catalana” (1996-2000) and “Vaccines Newsletter” (1997-2009).
Scientific production: more than 50 books about pediatric infection and vaccines topics.
More 200 publications. More than 500 presentations and different conferences at national and international congress.
Astrid Morer, Spain
Hospital Clinic of Barcelona
Dr. Astrid Morer is a Child and Adolescent Psychiatrist in Hospital Clinic of Barcelona. She studied in the University of Barcelona and graduated in medicine (MD) in 1995. She became specialist in psychiatry in 2000 and has worked as a clinician in child and adolescent psychiatry since 2004. She defended her academic dissertation on the immunological hypothesis of Obsessive Compulsive Disorder and Tourette Syndrome in 2007 at the University of Barcelona. She won a Alicia Koplowitz fellowship in 2009 and was a post-doc assistant researcher at Child Study Center at Yale University, USA during 10 months between 2009 and 2010. She is the PI of current project grants and Collaborative projects in the immunological aspects of TS and OCD. Since 2012 she is the Chief of the Child and Adolescent Hospitalization Psychiatry section, comprising the specialist level child adolescent psychiatric inpatient services and the tertiary level child and adolescent intensive outpatient programs and she is a clinical consultant in the OCD and Tourette Clinic. Her research interests focus on Tourette Disorder and Obsessive Compulsive Disorder particularly in the immune etiological hypothesis and have authored several papers and book chapters in the field.
Arnold Munnich, France
Necker-Enfants Malades Hospital
Sharon Nachman, USA
Stony Brook University School of Medicine
Dr. Sharon Nachman is a clinician scientist with over 20 years of NIH funding (U mechanism from the IMPAACT network) dedicated to developing clinical trials in children and adolescents. She completed her pediatrics training at Schneider Children’s Hospital, her Pediatric Infectious Disease fellowship at Lincoln Hospital in the South Bronx, and her training as a Physician Scientist at Rockefeller University, all in NYC. Currently the Associate Dean for Research and a Professor of Pediatrics at SUNY Stony Brook, she has been involved in the development of over 25 clinical trials, including 10 as protocol chair and 8 as vice chair. All studies have enrolled, analyzed and were published, and have changed the way we assess, treat or evaluate HIV infected and exposed children worldwide. As part of her HIV related studies, she has also developed studies evaluating new and older drugs and vaccines in TB infected or at risk children. She currently serves as the PI and chair of the IMPAACT Network.
Isabelle Paut, France
Bicêtre Hospital
Dr. Isabelle Paut
Head Pediatric Department
Pediatric Rheumatology
National reference center for auto-inflammatory disorders
Hôpital de Bicêtre, CHU
ACADEMIC QUALIFICATIONS:
1977 Baccalauréat série D
1988 University of Tropical Health and Medicine
1989 Qualification in Pediatrics
1990 Certificat de Maîtrise d’Immunologie. (Master I)
1991 University diploma of rheumatology and immunology.
1996 Master degree of immunology (Master II)
2000 Research director qualification
2002 Interfaculty diploma of medical teaching methods.
2002 University Scientific English diploma
TITLES AND EMPLOYMENTS
1986 Intern University hôpitaux de Marseilles.
1990 Fellow (Assistant des Hôpitaux – Chef de clinique) Marseille faculty of medicine.
1993 Hospital medical consultant
1996 Full time hospital physician. Pediatric rheumatology and emergency room
2000 University teaching diploma
2004 University professor of pediatrics, Head of the pediatric, pediatric rheumatology and emergency medicine. Le Kremlin Bicêtre (Assistance publique hôpitaux de Paris University of Paruis SUD)
2007 Coordinator of the national reference center for auto-inflammatory disorders
PUBLICATIONS
– 145 publications in Pubmed in June 2015: Koné-Paut I; Koné I, Paut IK
– H index 34
– >150 communications and posters presented at international meetings.
Cristina Ramos, Spain
Gregorio Marañón University Hospital
Cristina Ramos,
Work Center: Neonatology Division Gregorio Marañón University Hospital. Madrid, Spain.
Medicine studies: Degree in Medicine and Surgery.
Complutense University in Madrid. 1992-1998.
Speciality: Pediatric 1999-2003. Pediatric Department. Mostoles General Hospital, Madrid.
Sub-specialty: Neonatology 2002-2003. Neonatology Division. Pediatric Department. Gregorio Marañón University Hopital. Madrid.
Post Graduate Position.
• From 2003.-2004: Staff Member Pediatric Department. Clinical Assistant Mostoles General Hospital.
• From 2004-until now: Staff Member Neonatology Division. Clinical Assistant. Gregorio Marañón University Hospital. Madrid.
Courses (related to Neonatal Respiratory Support):
Assistant to I International Pediatric and Neonatal NIV meeting in Sant Joan de Deu. Barcelona September 2013.
Professor in two Courses of Mechanical Ventilation (Invasive and Non-invasive) organized by Respiratory Group of the Spanish Neonatoloy Society. 2013-2015.
Professor in 3 Courses of Pediatrics and Neonatal Ventilation of the Spanish Society of Pediatrics Intensive Care. 2005.
Professor in 10 Courses of Neonatal Resuscitation organized by Gregorio Marañón Hospital 2012-2015.
Shimon Reif, Israel
Hadassah Ein Kerem Medical Center
Prof. Shimon Reif he is currently the head of Pediatric department in Hadassah Ein Kerem Medical Center. He is graduated of Technion Medical School. He did his Residency at Tel Aviv Medical Center Following by 3 years of fellowship in Pediatric Gastroenterology in Children’s Hospital Buffalo NY. During this period he initiated his research in liver fibrosis focusing on modulation of ECM expression during development. After his return to Israel he became had of Pediatric GI and later head of department of Pediatrics at in Tel Aviv Medical Center. Professor Reif Spend a very successful sabbatical at David Brenner lab where he promoted his research by investigating signal transduction pathway of HSCs proliferation. In the last years his research is dedicated to the anti fibrotic mechanism of vitamin D. In addition he is the president of the Israeli pediatric GI association and associate editor of JPGN. He has more than 100 peer review publication in prestige journals.
Carlos Rodrigo, Spain
Vall d’Hebron University Hospital
Prof. Carlos Rodrigo,
Head of the Department of Pediatrics and Pediatric Specialities at the Vall d’Hebron University Hospital in Barcelona. Professor (Full) of Pediatrics in the Autonomous University of Barcelona.
Member of the Advisory Committee on Vaccines of Catalonia; Member of the Advisory Committee on Nosocomial Infections of Catalonia; Member of the Spanish Pediatric Infectious Disease Society; Board member of the Spanish Vaccines Association; Member of the Pediatrics Spanish Association; Member of the Clinical Microbiology and Infectious Diseases Spanish Society; Member of the Advisory Board of the Spanish National Plan of Antibiotic Resistance (Agencia Española de Medicamentos y Productos Sanitarios); Member of the European Society for Paediatric Infectious Diseases
Research/clinical interest areas: new vaccines, new antimicrobial drugs, antibiotic use and resistances development, pneumoccocal infections, respiratory infections, immunedeficiencies and immunosuppression infections, inflammatory response to infections.
Publications: chapters about infectious diseases in the main Spanish books of Pediatrics and Internal Medicines. Papers in peer review journals, active participation in National and International Congresses, reviewer in major journals (Pediatrics, Pediatric Infectious Diseases Journal, Acta Paediatrica, Pediatric Neprology, Clinical Infectious Diseases, Journal of Infection, Journal of Pediatrics, Scandinavian Journal of Infectious Diseases, Vaccine, European Respiratory Journal, BMC Public Health, BMC Infectious Disease, Thorax, Medicina Clínica, Enfermedades Infecciosas y Microbiología Clínica, Anales de Pediatría).
Pablo Rojo, Spain
University Hospital 12 October
Dr. Pablo Rojo
Degree/Certification:
2003 – Pediatric Specialist, HOSPITAL UNIVERSITARIO 12 DE OCTUBRE
2006 – PhD, Universidad Complutense de Madrid, Spain
1997 – MD, Universidad Complutense de Madrid, Spain
Current and previous positions including academic appointments:
2006 – Current – Associate Professor, HOSPITAL UNIVERSITARIO 12 DE OCTUBRE
2006 – Current – Associate Physician, Universidad Complutense de Madrid, Spain
2003 – 2006 – Associate Physician, Universidad Complutense de Madrid, Spain
MAIN CLINICAL TRIALS:
· BREATHER: PENTA 16 Study: Short-cycle therapy (5 days on/2 days off) in young
people with chronic HIV-infection. Ongoing.
· KONCERT: PENTA 18 Study: A Kaletra ONCE daily randomized trial of the
pharmacokinetics, safety and efficacy of twice-daily versus once-daily lopinavir/ritonavir
tablets as part of combination antiretroviral therapy in HIV-1 infected children.
· TICCH: PENTA 11 Study: Treatment interruption in children with chronic HIV-infection.
· PENPACT 1: A phase II/III randomized, open-label study of combination antiretroviral
regimens and treatment-switching strategies in HIV-1-infected antiretrivral naïve children >
30 days and < 18 years of age. · An Open-label, multicenter, multiple-dose pharmacokinetic, safety and efficacy trial of Maraviroc in combination with optimized background therapy for the treatment of ARVexperienced CCR-5 tropic HIV-1 infected children 2-18 years of age.
MAIN RECENT PUBLICATIONS:
Sainz T, Diaz L, Navarro ML, Rojo P, Blázquez D, Ramos JT, de José MI, Álvarez-Fuente M,
Serrano-Villar S, Mellado MJ, Muñoz-Fernández MA; Madrid Cohort of HIV-infected children
and adolescents, integrating the Pediatric branch of the National AIDS Research Network of
Spain (CORISPE). Cardiovascular biomarkers in vertically HIV-infected children without
metabolic abnormalities. Atherosclerosis. 2014 Apr;233(2):410-4.
Sainz T, Álvarez-Fuente M, Navarro ML, Díaz L, Rojo P, Blázquez D, de José MI, Ramos JT,
Serrano-Villar S, Martínez J, Medrano C, Muñoz-Fernández MÁ, Mellado MJ; Madrid Cohort of
HIV-infected children and adolescents integrated in the Pediatric branch of the Spanish
National AIDS Network (CoRISPE). Subclinical atherosclerosis and markers of immune
activation in HIV-infected children and adolescents: the CaroVIH Study. J Acquir Immune Defic
Syndr. 2014 Jan 1;65(1):42-9.
Barrios López M, Gómez González C, Orellana MÁ, Chaves F, Rojo P. Staphylococcus aureus
abscesses: methicillin-resistance or Panton-Valentine leukocidin presence? Arch Dis Child.
2013 Aug;98(8):608-10.
Tamar Steinberg, Israel
Tel Aviv University
Dr. Tamar Steinberg,
Sackler Faculty of Medicine
Tel Aviv University
Child Development and Rehabilitation Institute
Schneider Children’s Medical Center of Israel
EDUCATION
1985-1991 Technion, Israel Institute of Technology, Faculty of Medicine, Haifa, Israel
1987 B.Sc. in Medical Science
1985-1991 MD degree
Title of Doctoral Dissertation: Hematological complications in Von Willebrant factor deficiency.
ACADEMIC & PROFESSIONAL ACTIVITIES & ACHIEVEMENTS
2003-2004 Research Fellowship, Department of Child Psychiatry and Center for Social, Genetic and Developmental Psychiatry, Institute of Psychiatry, King’s College, UK
Professional Experience:
1991-1992 Internship, Rambam Medical Center, Haifa, Israel
1993-1997 Resident, Pediatrics, Schneider Children’s Medical Center of Israel (SCMCI) Petach Tikva, Israel
1998-2001 Resident, Pediatric Neurology, Department of Pediatric Neurology, SCMCI, Petach Tikva, Israel
Including: Three-month rotation in Child Development
Three-month rotation in Child Psychiatry
2001 Senior Consultant, Pediatric Neurology, Department of Pediatric Neurology, SCMCI, Petach Tikva, Israel
2002 Senior Consultant, Tourette clinic, Neuropsychiatric Department, SCMCI, Petach Tikva, Israel
2004-2012 Senior Neurologist, Department of Pediatric Neurology and Director of Tourette clinic, SCMCI, Petach Tikva, Israel
2010-2012 Senior Neurologist, Child Development Unit, SCMCI, Petach Tikva, Israel
2012-2013 Head, Child Development and Rehabilitation Unit, SCMCI, Petach Tikva, Israel
Santiago Pérez Tarazona, Spain
La Fe University & Polytechnic Hospital
Dr. Santiago Pérez Tarazona
EDUCATION AND TRAINING: MD Faculty of Medicine 15/06/1992 (University of Valencia, Spain), PhD in Medical Science Faculty of Medicine 14/10/2005, (University of Valencia, Spain)
CURRENT EMPLOYMENT – Position: Staff Doctor (Start date 01/02/2013) – Organization: Conselleria de Salut, Institution: La Fe University & Polytechnic Hospital (Valencia, Spain), Department: Division of Neonatology, Employment status: Statutory Staff
ACADEMIC AND PROFESSIONAL EXPERIENCE From 1995-1998 Residency training in Pediatrics in Hospital La Fe. Valencia. From 1999-2012 Staff Doctor Pediatric Unit in Hospital de La Ribera, Alzira.Valencia, and from 2013 until preset staff Doctor Division of Neonatology Hospital La Fe. Valencia.
RESEARCH FIELDS: Bronchopulmonary dysplasia, Recurrent wheezing, Pediatric asthma, Pediatric chronic respiratory disease.
Federico Martinon-Torres, Spain
Hospital Clínico Universitario de Santiago
Dr. Federico Martinón-Torres Born in Orense (Spain) in 1971, Federico Martinón-Torres currently is consultant in Pediatrics and head of Translational Pediatrics and Infectious Diseases at the Hospital Clínico Universitario de Santiago (Spain), nationally accredited as Professor in Pediatrics (ANECA) and Academic of the Royal Academy of Medicine and Surgery of Galicia. He graduated at the University of Santiago de Compostela and completed his medical training at the Hope Children’s Hospital of Chicago and at the Children’s Memorial Hospital of Chicago, before obtaining a PhD on the application of heliox in infants with bronchiolitis (awarded the national PhD prize). He has been granted over 25 prizes and awards to academic merits, including Best National Graduate in Medicine and Surgery (1995) and Best National Resident of all sub-specialities (2000).
He has published over 300 articles (Impact factor > 400 JCR 2014), 6 books and 120 chapters in refereed journals and books. He has delivered more than 300 lectures in over 30 countries. His main research interests are: infectious diseases, vaccines, pneumococcal diseases, bronchiolitis, meningococcal disease and heliox therapy. He is directing or involved as coordinator or lead investigator in 25 ongoing international and multicentre clinical trials and research projects, including 2 FP7 (EUCLIDS and PREPARE) and 2 H2020 (PoC-ID and PERFORM) projects. Member of more than 15 national and international consultive and expert advisory boards on pneumococcal disease, RSV, meningococcal disease, heliox, rotavirus, flu and human papillomavirus, and of over 20 professional and academic international societies. He also collaborates with WHO-Europe.
Carine Wouters, Belgium
University Hospitals Leuven
Dr. Carine Wouters is a pediatric rheumatologist working at Leuven University Hospital in Leuven, Belgium.
She is head of the clinical department of pediatric rheumatology and immune-inflammatory diseases at the Leuven University Children’s hospital, and is the chair for clinical affairs in the PReS council.
Her major research interests comprise systemic juvenile idiopathic arthritis and macrophage activation syndrome (in collaboration with research group of Immunobiology, Patrick Matthys, Leuven) as well as granulomatous inflammatory diseases in children with a special interest to Blau syndrome. In collaboration with the research group Genetics of Autoimmunity (Adrian Liston, Leuven University), her research activity also involves the search for genetic causes in early-onset autoinflammatory diseases.